Metformin Vitabalans

Metformin, the active ingredient in Metformin Vitabalans, is a biguanide presented as an oral tablet for oral use. It lowers elevated blood glucose by improving insulin sensitivity and decreasing hepatic glucose production, and is indicated for adults with type 2 diabetes mellitus. It is commonly prescribed as part of a comprehensive diabetes management plan that includes diet and exercise.

GNH USA supplies Metformin Vitabalans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for importers.

Metformin is used to improve glycemic control in disorders of glucose metabolism.

Type 2 diabetes mellitus: reduces fasting and post‑prandial blood glucose levels, supporting overall glycemic control. Prediabetes (impaired glucose tolerance): lowers elevated glucose, helping to delay or prevent progression to type 2 diabetes. Polycystic ovary syndrome (off‑label): improves insulin sensitivity, which can aid in regularizing menstrual cycles and reducing androgen levels.

Metformin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, and loss of appetite. - Diarrhea: loose stools, often transient. - Metallic taste: temporary alteration in taste perception.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal accumulation of lactate. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic failure: rare liver injury.

When prescribing Metformin, several precautionary measures should be observed to minimize risk. - Renal function assessment: evaluate creatinine clearance before initiation and periodically. - Hepatic impairment: avoid or use with caution in patients with liver disease. - Lactic acidosis risk: discontinue before surgeries or radiographic contrast procedures. - Vitamin B12 monitoring: check levels during long‑term therapy. - Pregnancy and lactation: assess benefit‑risk ratio; use only if clearly needed. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Metformin can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate lactic acidosis; suspend Metformin before and after exposure. - Cimetidine: increases Metformin plasma concentrations, raising toxicity risk. - Alcohol excess: enhances risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics (loop or thiazide): can affect renal clearance of Metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes. - Oral contraceptives: may slightly increase Metformin levels.